Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss ...

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Every single fault hit No. 15 Tennessee at critical moments in its third one-possession loss of the season. And in a game where it couldn't force enough turnovers to create a cushion to fall back ...

Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...

We recently published a list of 17 Best Stocks for Kids According to Jim Cramer. In this article, we are going to take a look ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund.

A battle over how to treat childhood obesity is brewing between those in favour and others who warn of the effects on growing bodies ...

Novo Nordisk faces challenges but its pipeline remains strong. Find out why NVO stock could deliver high double-digit returns ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.